Omnicell (OMCL) Financials

$43.14 -0.16 (-0.36%)

As of 09:58 AM Eastern

Annual Income Statements for Omnicell

This table shows Omnicell's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	31	9.76	31	38	61	32	78	5.65	-20	13	2.05
Consolidated Net Income / (Loss)	31	9.76	31	38	61	32	78	5.65	-20	13	2.05
Net Income / (Loss) Continuing Operations	31	9.76	31	38	61	32	78	5.65	-20	13	2.05
Total Pre-Tax Income	46	13	4.51	36	74	29	66	-2.45	-20	26	11
Total Operating Income	49	21	11	44	78	36	90	-2.32	-35	0.34	5.16
Total Gross Profit	248	317	319	372	437	413	555	589	497	471	503
Total Revenue	485	696	713	787	897	892	1,132	1,296	1,147	1,112	1,185
Operating Revenue	485	696	713	787	897	892	1,132	1,296	1,147	1,112	1,185
Total Cost of Revenue	237	379	394	415	460	479	577	707	650	641	681
Operating Cost of Revenue	237	379	394	415	460	479	577	707	650	641	681
Total Operating Expenses	199	296	307	328	359	378	465	591	532	471	498
Selling, General & Admin Expense	168	238	241	263	290	308	389	486	435	380	410
Research & Development Expense	35	58	66	65	69	70	76	105	97	90	89
Total Other Income / (Expense), net	-2.39	-8.43	-6.63	-8.78	-4.42	-6.18	-24	-0.13	15	25	6.17
Other Income / (Expense), net	-2.39	-8.43	-6.63	-8.78	-4.42	-6.18	-24	-0.13	15	25	6.17
Income Tax Expense	15	3.22	-26	-2.11	13	-2.85	-12	-8.10	0.26	13	9.27
Basic Earnings per Share	$0.86	$0.27	$0.81	$0.96	$1.48	$0.76	$1.79	$0.13	($0.45)	$0.27	$0.04
Weighted Average Basic Shares Outstanding	35.86M	36.16M	37.48M	39.24M	41.46M	42.58M	43.48M	44.40M	45.21M	46.05M	45.97M
Diluted Earnings per Share	$0.84	$0.26	$0.79	$0.93	$1.43	$0.74	$1.62	$0.12	($0.45)	$0.27	$0.04
Weighted Average Diluted Shares Outstanding	36.72M	36.86M	38.71M	40.56M	42.94M	43.74M	47.94M	45.89M	45.21M	46.26M	46.36M
Weighted Average Basic & Diluted Shares Outstanding	35.80M	30.20M	37.70M	39.30M	42.47M	43.04M	44.42M	44.99M	45.92M	46.76M	45.44M

This table shows Omnicell's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	5.55	-14	-16	3.74	8.63	16	-7.02	5.64	5.46	-2.03	11
Consolidated Net Income / (Loss)	5.55	-14	-16	3.74	8.63	16	-7.02	5.64	5.46	-2.03	11
Net Income / (Loss) Continuing Operations	5.55	-14	-16	3.74	8.63	16	-7.02	5.64	5.46	-2.03	11
Total Pre-Tax Income	7.38	-19	-18	8.20	12	24	-9.53	10	9.70	0.70	17
Total Operating Income	3.71	-23	-22	3.22	6.56	12	-12	8.12	8.24	0.42	17
Total Gross Profit	132	105	93	114	122	142	111	128	135	130	140
Total Revenue	299	259	246	277	282	307	270	291	311	314	310
Operating Revenue	299	259	246	277	282	307	270	291	311	314	310
Total Cost of Revenue	167	153	154	162	160	165	159	163	176	184	170
Operating Cost of Revenue	167	153	154	162	160	165	159	163	176	184	170
Total Operating Expenses	128	129	114	111	116	129	123	120	126	130	124
Selling, General & Admin Expense	104	102	92	90	94	103	102	98	102	107	102
Research & Development Expense	24	27	22	21	21	26	21	22	24	23	22
Total Other Income / (Expense), net	3.67	4.85	4.02	4.97	5.06	11	2.09	2.33	1.46	0.28	0.05
Other Income / (Expense), net	3.67	4.85	4.02	4.97	5.06	11	2.09	2.33	1.46	0.28	0.05
Income Tax Expense	1.83	-4.14	-2.16	4.46	3.00	7.76	-2.51	4.81	4.24	2.73	5.55
Basic Earnings per Share	$0.12	($0.32)	($0.34)	$0.08	$0.19	$0.34	($0.15)	$0.12	$0.12	($0.05)	$0.25
Weighted Average Basic Shares Outstanding	45.33M	45.21M	45.73M	45.95M	46.15M	46.05M	46.60M	46.79M	45.54M	45.97M	45.32M
Diluted Earnings per Share	$0.12	($0.32)	($0.34)	$0.08	$0.19	$0.34	($0.15)	$0.12	$0.12	($0.05)	$0.25
Weighted Average Diluted Shares Outstanding	45.60M	45.21M	45.73M	46.04M	46.43M	46.26M	46.60M	46.99M	45.90M	46.36M	45.94M
Weighted Average Basic & Diluted Shares Outstanding	45.47M	45.92M	45.92M	45.99M	46.32M	46.76M	46.84M	45.93M	44.88M	45.44M	45.48M

This table details how cash moves in and out of Omnicell's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-44	-28	-22	35	60	363	-134	-2.79	148	-102	-148
Net Cash From Operating Activities	38	50	25	104	145	186	232	78	181	188	127
Net Cash From Continuing Operating Activities	38	50	25	104	145	186	232	78	181	188	127
Net Income / (Loss) Continuing Operations	31	9.76	31	38	61	32	78	5.65	-20	13	2.05
Consolidated Net Income / (Loss)	31	9.76	31	38	61	32	78	5.65	-20	13	2.05
Depreciation Expense	26	58	52	51	54	61	73	87	87	82	79
Amortization Expense	0.00	1.59	1.59	2.29	13	17	34	16	13	11	10
Non-Cash Adjustments To Reconcile Net Income	12	14	18	24	32	37	47	84	76	36	47
Changes in Operating Assets and Liabilities, net	-30	-34	-77	-12	-14	39	0.26	-115	26	46	-11
Net Cash From Investing Activities	-46	-341	-35	-54	-62	-280	-412	-59	-55	-53	-60
Net Cash From Continuing Investing Activities	-46	-341	-35	-54	-62	-280	-412	-59	-55	-53	-60
Purchase of Property, Plant & Equipment	-7.54	-13	-15	-24	-16	-23	-29	-48	-41	-36	-40
Acquisitions	-26	-314	-4.61	0.00	0.00	-225	-354	2.07	0.00	0.00	-2.43
Other Investing Activities, net	-12	-14	-15	-31	-46	-32	-29	-13	-14	-16	-18
Net Cash From Financing Activities	-37	264	-9.88	-14	-23	456	47	-21	23	-236	-218
Net Cash From Continuing Financing Activities	-37	264	-9.88	-14	-23	456	47	-21	23	-236	-218
Repayment of Debt	0.00	-35	-105	-77	-92	-201	0.00	0.00	-2.97	0.00	-175
Repurchase of Preferred Equity	-	-	-	-	-	-	-	-	0.00	-391	0.00
Repurchase of Common Equity	-50	-	-	0.00	0.00	-53	0.00	-52	0.00	0.00	-78
Issuance of Debt	0.00	287	59	0.00	0.00	710	-	0.00	0.00	166	0.00
Issuance of Common Equity	17	18	44	70	79	106	67	40	23	39	17
Other Financing Activities, net	-3.63	-6.49	-8.29	-6.78	-9.67	-105	-20	-8.93	3.17	-49	17
Effect of Exchange Rate Changes	-0.00	-0.06	-2.03	-1.23	0.15	0.44	-0.97	-0.94	-1.35	-1.72	3.80
Cash Interest Paid	0.08	5.34	6.55	7.49	3.58	0.52	1.92	1.44	1.44	1.62	2.20

This table details how cash moves in and out of Omnicell's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	45	38	49	28	15	-194	16	17	-206	26	40
Net Cash From Operating Activities	57	38	50	59	23	56	26	43	28	30	55
Net Cash From Continuing Operating Activities	57	38	50	59	23	56	26	43	28	30	55
Net Income / (Loss) Continuing Operations	5.55	-14	-16	3.74	8.63	16	-7.02	5.64	5.46	-2.03	11
Consolidated Net Income / (Loss)	5.55	-14	-16	3.74	8.63	16	-7.02	5.64	5.46	-2.03	11
Depreciation Expense	22	22	21	21	20	20	20	20	19	20	19
Amortization Expense	3.06	3.26	2.90	2.94	2.35	3.12	2.58	2.79	2.66	2.47	2.43
Non-Cash Adjustments To Reconcile Net Income	17	17	11	16	12	-2.84	7.80	17	11	12	7.65
Changes in Operating Assets and Liabilities, net	9.93	10	31	15	-20	20	2.58	-1.84	-9.91	-2.27	14
Net Cash From Investing Activities	-14	-12	-12	-14	-13	-14	-16	-16	-14	-14	-16
Net Cash From Continuing Investing Activities	-14	-12	-12	-14	-13	-14	-16	-16	-14	-14	-16
Purchase of Property, Plant & Equipment	-11	-9.07	-8.96	-9.55	-8.87	-9.09	-11	-12	-9.75	-7.71	-12
Other Investing Activities, net	-3.56	-3.30	-3.38	-4.00	-4.47	-4.48	-4.57	-4.14	-4.53	-4.28	-3.43
Net Cash From Financing Activities	2.83	13	12	-17	3.55	-234	4.04	-11	-220	9.10	2.39
Net Cash From Continuing Financing Activities	2.83	13	12	-17	3.55	-234	4.04	-11	-220	9.10	2.39
Issuance of Common Equity	7.83	0.18	8.04	0.10	5.00	25	8.27	-	6.90	1.71	7.76
Other Financing Activities, net	-5.01	16	3.88	-17	-1.45	-34	-4.23	4.18	10	7.39	-5.37
Effect of Exchange Rate Changes	-0.61	-0.89	-0.56	-0.25	1.68	-2.60	1.57	1.74	-0.05	0.55	-1.09

This table presents Omnicell's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	579	935	1,016	1,081	1,241	1,825	2,142	2,211	2,227	2,121	1,975
Total Current Assets	264	315	352	397	483	829	781	882	928	815	680
Cash & Equivalents	82	54	32	67	127	486	349	330	468	369	197
Accounts Receivable	108	150	190	196	218	190	241	299	252	256	217
Inventories, net	47	69	96	101	108	96	120	148	110	89	101
Prepaid Expenses	20	29	20	21	14	16	22	27	26	26	34
Other Current Assets	7.77	13	13	12	15	41	48	77	72	75	132
Plant, Property, & Equipment, net	32	42	43	52	54	59	71	94	109	113	120
Total Noncurrent Assets	282	578	621	633	703	936	1,291	1,235	1,191	1,193	1,175
Noncurrent Note & Lease Receivables	14	21	15	17	20	22	18	33	43	53	61
Goodwill	148	328	338	336	337	499	739	734	736	735	738
Intangible Assets	90	190	168	144	125	168	278	243	211	188	170
Noncurrent Deferred & Refundable Income Taxes	2.36	4.04	9.45	15	14	15	16	22	33	57	58
Other Noncurrent Operating Assets	28	35	91	121	208	231	240	203	168	160	147
Total Liabilities & Shareholders' Equity	579	935	1,016	1,081	1,241	1,825	2,142	2,211	2,227	2,121	1,975
Total Liabilities	176	503	462	402	396	857	996	1,081	1,038	878	743
Total Current Liabilities	125	181	205	205	237	276	876	428	368	596	477
Accounts Payable	23	27	48	38	46	40	72	63	45	52	44
Accrued Expenses	30	31	36	43	56	80	133	173	149	168	204
Current Deferred Revenue	54	88	79	82	91	100	112	119	122	141	172
Current Employee Benefit Liabilities	18	27	27	42	44	56	71	73	52	60	57
Total Noncurrent Liabilities	52	323	257	197	159	581	120	652	670	282	266
Long-Term Debt	0.00	246	195	135	50	467	0.00	567	570	166	168
Noncurrent Deferred Revenue	18	17	11	11	7.08	5.67	20	37	59	76	63
Noncurrent Deferred & Payable Income Tax Liabilities	22	52	41	41	39	40	52	2.10	1.62	1.11	0.68
Other Noncurrent Operating Liabilities	12	8.21	9.83	9.56	62	68	48	46	40	38	35
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	402	432	554	680	845	968	1,147	1,130	1,189	1,243	1,232
Total Preferred & Common Equity	402	432	554	680	845	968	1,147	1,130	1,189	1,243	1,232
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	402	432	554	680	845	968	1,147	1,130	1,189	1,243	1,232
Common Stock	490	526	586	678	781	920	1,025	1,047	1,122	1,168	1,224
Retained Earnings	100	100	160	197	259	291	369	391	370	383	385
Treasury Stock	-185	-185	-185	-185	-185	-238	-238	-290	-	-290	-368
Accumulated Other Comprehensive Income / (Loss)	-2.73	-9.52	-6.11	-11	-9.45	-5.52	-8.41	-17	-13	-17	-8.85

This table presents Omnicell's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	2,180	2,251	2,194	2,222	2,284	2,292	2,304	2,151	2,145	1,949	2,004
Total Current Assets	849	935	881	914	990	996	1,011	840	845	660	722
Cash & Equivalents	266	340	399	447	512	557	571	387	399	180	239
Accounts Receivable	354	322	274	273	249	241	252	252	233	246	250
Inventories, net	147	141	131	116	103	93	95	91	106	107	99
Prepaid Expenses	25	28	24	28	27	22	29	27	29	30	34
Other Current Assets	57	103	54	50	99	82	65	83	78	96	100
Plant, Property, & Equipment, net	88	98	103	107	109	111	112	116	119	120	122
Total Noncurrent Assets	1,242	1,217	1,209	1,201	1,185	1,185	1,181	1,196	1,182	1,169	1,160
Noncurrent Note & Lease Receivables	34	33	35	42	44	50	51	53	54	54	58
Goodwill	731	735	736	734	735	735	737	736	738	738	737
Intangible Assets	251	235	227	219	205	199	194	183	177	172	165
Noncurrent Deferred & Refundable Income Taxes	17	30	33	36	37	41	42	61	60	56	54
Other Noncurrent Operating Assets	209	186	179	170	163	159	157	164	152	149	145
Total Liabilities & Shareholders' Equity	2,180	2,251	2,194	2,222	2,284	2,292	2,304	2,151	2,145	1,949	2,004
Total Liabilities	1,044	1,108	1,030	1,034	1,095	1,089	1,072	894	882	728	747
Total Current Liabilities	377	454	370	369	416	407	962	608	594	457	483
Accounts Payable	74	63	47	50	43	50	48	53	62	62	58
Accrued Expenses	146	199	146	150	167	158	144	174	152	165	166
Current Deferred Revenue	114	143	125	125	165	150	152	160	154	179	212
Current Employee Benefit Liabilities	43	48	52	44	41	49	45	46	52	50	46
Total Noncurrent Liabilities	668	654	660	665	679	682	111	287	287	271	264
Long-Term Debt	566	567	568	569	570	571	0.00	167	167	167	168
Noncurrent Deferred Revenue	35	42	49	55	65	68	70	78	80	67	63
Noncurrent Deferred & Payable Income Tax Liabilities	16	1.56	1.51	1.57	1.49	1.33	1.41	1.17	1.31	1.26	0.64
Other Noncurrent Operating Liabilities	51	43	42	39	42	41	40	41	39	36	33
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,135	1,143	1,164	1,187	1,189	1,203	1,231	1,257	1,264	1,221	1,257
Total Preferred & Common Equity	1,135	1,143	1,164	1,187	1,189	1,203	1,231	1,257	1,264	1,221	1,257
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,135	1,143	1,164	1,187	1,189	1,203	1,231	1,257	1,264	1,221	1,257
Common Stock	1,031	1,073	1,089	1,110	1,139	1,150	1,165	1,185	1,196	1,212	1,239
Retained Earnings	419	376	379	385	355	358	367	376	382	387	396
Accumulated Other Comprehensive Income / (Loss)	-24	-16	-14	-17	-15	-15	-10	-14	-7.52	-9.26	-11
Other Equity Adjustments	-	-	-	-	-	-290	-	-290	-	-	-368

This table displays calculated financial ratios and metrics derived from Omnicell's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.90%	43.62%	2.42%	10.47%	13.94%	-0.54%	26.88%	14.48%	-11.48%	-3.04%	6.53%
EBITDA Growth	4.52%	1.45%	-21.00%	54.93%	57.14%	-23.49%	61.21%	-41.68%	-20.85%	49.21%	-15.55%
EBIT Growth	-4.66%	-71.94%	-65.23%	689.36%	107.58%	-60.30%	124.90%	-103.72%	-719.73%	227.28%	-55.75%
NOPAT Growth	3.69%	-50.25%	368.40%	-37.62%	38.23%	-40.05%	170.89%	-101.54%	-1,400.99%	100.68%	466.62%
Net Income Growth	0.79%	-68.28%	212.81%	23.63%	62.58%	-47.51%	141.81%	-92.74%	-460.68%	161.51%	-83.62%
EPS Growth	1.20%	-69.05%	203.85%	17.72%	53.76%	-48.25%	118.92%	-92.59%	-475.00%	160.00%	-85.19%
Operating Cash Flow Growth	-40.94%	29.66%	-50.23%	318.64%	39.48%	28.18%	24.72%	-66.45%	132.83%	3.66%	-32.19%
Free Cash Flow Firm Growth	-306.17%	-1,149.32%	91.39%	222.94%	43.48%	-416.42%	-63.27%	64.49%	162.42%	48.12%	-83.05%
Invested Capital Growth	21.18%	97.16%	15.97%	2.16%	2.70%	23.53%	35.52%	6.27%	-5.54%	-5.87%	-0.98%
Revenue Q/Q Growth	1.84%	6.90%	3.05%	1.99%	4.25%	0.10%	5.78%	-1.02%	-3.27%	4.51%	0.60%
EBITDA Q/Q Growth	-0.78%	15.06%	-0.03%	3.63%	6.12%	0.09%	-2.15%	-30.98%	25.69%	50.96%	-19.07%
EBIT Q/Q Growth	-4.50%	16.84%	48.47%	6.13%	7.81%	-21.62%	-9.68%	-106.15%	45.81%	254.88%	-66.91%
NOPAT Q/Q Growth	-3.39%	18.41%	174.89%	-30.06%	9.85%	2.65%	-2.03%	-102.83%	30.07%	100.67%	-90.63%
Net Income Q/Q Growth	-4.89%	20.43%	254.74%	-30.34%	13.51%	-15.08%	-2.99%	-88.24%	40.79%	170.85%	-89.70%
EPS Q/Q Growth	-4.55%	18.18%	259.09%	-32.61%	11.72%	-15.91%	-5.81%	-88.24%	40.00%	169.23%	-90.70%
Operating Cash Flow Q/Q Growth	4.64%	-14.82%	-44.22%	71.28%	-8.01%	28.86%	-6.76%	40.75%	-19.45%	10.54%	-16.94%
Free Cash Flow Firm Q/Q Growth	7.71%	-15.17%	3.86%	188.44%	-37.51%	-516.81%	8.70%	68.96%	-43.27%	46.14%	-62.71%
Invested Capital Q/Q Growth	-4.08%	4.60%	11.36%	-1.59%	2.76%	26.28%	15.57%	-4.77%	-1.44%	-1.45%	-0.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	51.17%	45.56%	44.71%	47.29%	48.71%	46.32%	49.00%	45.45%	43.31%	42.35%	42.49%
EBITDA Margin	14.83%	10.48%	8.08%	11.34%	15.64%	12.03%	15.28%	7.78%	6.96%	10.71%	8.49%
Operating Margin	10.04%	3.08%	1.56%	5.64%	8.73%	3.98%	7.91%	-0.18%	-3.04%	0.03%	0.44%
EBIT Margin	9.54%	1.86%	0.63%	4.52%	8.24%	3.29%	5.83%	-0.19%	-1.75%	2.30%	0.96%
Profit (Net Income) Margin	6.35%	1.40%	4.28%	4.79%	6.84%	3.61%	6.88%	0.44%	-1.78%	1.13%	0.17%
Tax Burden Percent	66.52%	75.19%	676.37%	105.93%	82.96%	109.69%	117.94%	-230.25%	101.31%	48.96%	18.12%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	33.48%	24.82%	-576.37%	-5.93%	17.04%	-9.69%	-17.94%	0.00%	0.00%	51.04%	81.88%
Return on Invested Capital (ROIC)	11.07%	3.38%	11.06%	6.36%	8.58%	4.54%	9.45%	-0.12%	-1.84%	0.01%	0.08%
ROIC Less NNEP Spread (ROIC-NNEP)	12.60%	-7.41%	-12.72%	-1.21%	90.18%	18.67%	-36.60%	3.75%	0.55%	33.80%	-3.81%
Return on Net Nonoperating Assets (RNNOA)	-3.31%	-1.04%	-4.87%	-0.24%	-0.53%	-0.99%	-2.08%	0.62%	0.08%	1.02%	0.09%
Return on Equity (ROE)	7.76%	2.34%	6.19%	6.12%	8.05%	3.55%	7.36%	0.50%	-1.76%	1.03%	0.17%
Cash Return on Invested Capital (CROIC)	-8.08%	-62.01%	-3.73%	4.22%	5.91%	-16.51%	-20.72%	-6.20%	3.86%	6.06%	1.07%
Operating Return on Assets (OROA)	8.12%	1.71%	0.46%	3.40%	6.37%	1.91%	3.33%	-0.11%	-0.91%	1.18%	0.55%
Return on Assets (ROA)	5.40%	1.29%	3.13%	3.60%	5.28%	2.10%	3.92%	0.26%	-0.92%	0.58%	0.10%
Return on Common Equity (ROCE)	7.76%	2.34%	6.19%	6.12%	8.05%	3.55%	7.36%	0.50%	-1.76%	1.03%	0.17%
Return on Equity Simple (ROE_SIMPLE)	7.64%	2.26%	5.51%	5.55%	7.26%	3.33%	6.79%	0.50%	-1.71%	1.01%	0.00%
Net Operating Profit after Tax (NOPAT)	32	16	75	47	65	39	106	-1.63	-24	0.17	0.93
NOPAT Margin	6.68%	2.31%	10.58%	5.97%	7.25%	4.37%	9.33%	-0.13%	-2.13%	0.01%	0.08%
Net Nonoperating Expense Percent (NNEP)	-1.53%	10.79%	23.78%	7.56%	-81.61%	-14.13%	46.05%	-3.88%	-2.39%	-33.78%	3.89%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-0.10%	-1.39%	0.01%	0.07%
Cost of Revenue to Revenue	48.83%	54.44%	55.29%	52.71%	51.29%	53.68%	51.00%	54.55%	56.69%	57.65%	57.51%
SG&A Expenses to Revenue	34.58%	34.18%	33.88%	33.42%	32.32%	34.48%	34.40%	37.53%	37.89%	34.19%	34.57%
R&D to Revenue	7.26%	8.31%	9.26%	8.24%	7.65%	7.86%	6.69%	8.10%	8.47%	8.13%	7.48%
Operating Expenses to Revenue	41.13%	42.49%	43.14%	41.65%	39.97%	42.34%	41.09%	45.63%	46.35%	42.32%	42.05%
Earnings before Interest and Taxes (EBIT)	46	13	4.51	36	74	29	66	-2.45	-20	26	11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	72	73	58	89	140	107	173	101	80	119	101
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.74	2.87	3.32	3.57	4.05	5.25	6.91	1.99	1.44	1.66	1.65
Price to Tangible Book Value (P/TBV)	6.68	0.00	37.95	12.13	8.93	16.93	60.91	14.72	7.07	6.44	6.28
Price to Revenue (P/Rev)	2.27	1.78	2.58	3.08	3.82	5.69	7.00	1.74	1.49	1.85	1.72
Price to Earnings (P/E)	35.80	126.89	60.28	64.32	55.87	157.72	101.85	398.59	0.00	164.55	990.70
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.79%	0.79%	1.66%	1.55%	1.79%	0.63%	0.98%	0.25%	0.00%	0.61%	0.10%
Enterprise Value to Invested Capital (EV/IC)	3.18	2.28	2.76	3.34	4.36	5.33	6.27	1.82	1.40	1.67	1.67
Enterprise Value to Revenue (EV/Rev)	2.10	2.07	2.83	3.17	3.73	5.67	7.13	1.92	1.58	1.83	1.69
Enterprise Value to EBITDA (EV/EBITDA)	14.17	19.71	35.02	27.95	23.88	47.14	46.64	24.66	22.70	17.07	19.92
Enterprise Value to EBIT (EV/EBIT)	22.03	110.79	447.12	70.05	45.31	172.37	122.23	0.00	0.00	79.46	176.95
Enterprise Value to NOPAT (EV/NOPAT)	31.50	89.33	26.76	53.05	51.53	129.82	76.43	0.00	0.00	12,324.22	2,143.41
Enterprise Value to Operating Cash Flow (EV/OCF)	26.47	28.81	81.24	24.00	23.10	27.22	34.81	31.98	10.01	10.83	15.74
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	79.90	74.77	0.00	0.00	0.00	35.34	26.77	155.61
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.59	0.38	0.20	0.06	0.48	0.43	0.50	0.48	0.27	0.14
Long-Term Debt to Equity	0.00	0.57	0.35	0.20	0.06	0.48	0.00	0.50	0.48	0.13	0.14
Financial Leverage	-0.26	0.14	0.38	0.20	-0.01	-0.05	0.06	0.16	0.15	0.03	-0.02
Leverage Ratio	1.44	1.82	1.98	1.70	1.52	1.69	1.88	1.91	1.91	1.79	1.65
Compound Leverage Factor	1.44	1.82	1.98	1.70	1.52	1.69	1.88	1.91	1.91	1.79	1.65
Debt to Total Capital	0.00%	37.06%	27.49%	16.61%	5.59%	32.56%	29.86%	33.39%	32.39%	21.51%	11.98%
Short-Term Debt to Total Capital	0.00%	1.23%	1.99%	0.00%	0.00%	0.00%	29.86%	0.00%	0.00%	11.01%	0.00%
Long-Term Debt to Total Capital	0.00%	35.83%	25.50%	16.61%	5.59%	32.56%	0.00%	33.39%	32.39%	10.50%	11.98%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	62.94%	72.51%	83.39%	94.42%	67.44%	70.14%	66.61%	67.61%	78.49%	88.02%
Debt to EBITDA	0.00	3.48	3.65	1.52	0.36	4.35	2.82	5.62	7.13	2.86	1.67
Net Debt to EBITDA	0.00	2.74	3.08	0.76	-0.55	-0.17	0.80	2.34	1.27	-0.24	-0.29
Long-Term Debt to EBITDA	0.00	3.37	3.38	1.52	0.36	4.35	0.00	5.62	7.13	1.40	1.67
Debt to NOPAT	0.00	15.79	2.79	2.88	0.77	11.99	4.62	-348.42	-23.34	2,064.93	179.26
Net Debt to NOPAT	0.00	12.41	2.36	1.45	-1.19	-0.48	1.32	-145.26	-4.17	-172.60	-30.94
Long-Term Debt to NOPAT	0.00	15.27	2.59	2.88	0.77	11.99	0.00	-348.42	-23.34	1,008.44	179.26
Altman Z-Score	5.38	2.59	3.50	4.93	6.65	4.68	5.59	2.33	2.01	2.35	2.66
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.12	1.74	1.72	1.94	2.04	3.00	0.89	2.06	2.52	1.37	1.43
Quick Ratio	1.53	1.13	1.08	1.29	1.46	2.45	0.67	1.47	1.96	1.05	0.87
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-24	-295	-25	31	45	-142	-231	-82	51	76	13
Operating Cash Flow to CapEx	510.29%	371.14%	161.88%	438.73%	912.34%	813.72%	800.25%	163.63%	436.64%	514.83%	314.98%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.85	0.92	0.73	0.75	0.77	0.58	0.57	0.60	0.52	0.51	0.58
Accounts Receivable Turnover	5.08	5.39	4.19	4.08	4.33	4.37	5.25	4.80	4.16	4.38	5.01
Inventory Turnover	6.06	6.54	4.76	4.21	4.41	4.69	5.34	5.29	5.05	6.45	7.19
Fixed Asset Turnover	14.15	18.73	16.85	16.73	16.97	15.75	17.39	15.70	11.33	10.05	10.18
Accounts Payable Turnover	11.25	15.24	10.46	9.61	10.90	11.05	10.33	10.48	12.00	13.25	14.23
Days Sales Outstanding (DSO)	71.83	67.73	87.15	89.54	84.35	83.55	69.49	76.10	87.74	83.42	72.90
Days Inventory Outstanding (DIO)	60.27	55.83	76.61	86.64	82.85	77.86	68.35	69.05	72.31	56.57	50.77
Days Payable Outstanding (DPO)	32.45	23.95	34.90	37.97	33.48	33.03	35.35	34.82	30.43	27.55	25.65
Cash Conversion Cycle (CCC)	99.65	99.61	128.87	138.22	133.72	128.38	102.49	110.32	129.62	112.44	98.02
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	320	631	732	748	768	949	1,286	1,366	1,291	1,215	1,203
Invested Capital Turnover	1.66	1.46	1.05	1.06	1.18	1.04	1.01	0.98	0.86	0.89	0.98
Increase / (Decrease) in Invested Capital	56	311	101	16	20	181	337	81	-76	-76	-12
Enterprise Value (EV)	1,019	1,438	2,017	2,495	3,350	5,059	8,068	2,487	1,813	2,034	2,004
Market Capitalization	1,101	1,238	1,840	2,427	3,427	5,078	7,929	2,251	1,711	2,062	2,033
Book Value per Share	$11.36	$11.82	$14.61	$17.15	$20.15	$22.87	$26.10	$25.31	$26.15	$26.84	$27.45
Tangible Book Value per Share	$4.65	($2.37)	$1.28	$5.05	$9.15	$7.09	$2.96	$3.43	$5.32	$6.92	$7.21
Total Capital	402	686	764	815	895	1,435	1,635	1,697	1,759	1,584	1,399
Total Debt	0.00	254	210	135	50	467	488	567	570	341	168
Total Long-Term Debt	0.00	246	195	135	50	467	0.00	567	570	166	168
Net Debt	-82	200	178	68	-77	-19	139	236	102	-28	-29
Capital Expenditures (CapEx)	7.54	13	15	24	16	23	29	48	41	36	40
Debt-free, Cash-free Net Working Capital (DFCFNWC)	57	88	130	125	119	67	44	123	92	25	6.94
Debt-free Net Working Capital (DFNWC)	139	143	162	193	246	553	393	453	560	394	203
Net Working Capital (NWC)	139	134	147	193	246	553	-95	453	560	220	203
Net Nonoperating Expense (NNE)	1.59	6.34	45	9.30	3.67	6.78	28	-7.27	-4.04	-12	-1.12
Net Nonoperating Obligations (NNO)	-82	200	178	68	-77	-19	139	236	102	-28	-29
Total Depreciation and Amortization (D&A)	26	60	53	54	66	78	107	103	100	94	89
Debt-free, Cash-free Net Working Capital to Revenue	11.82%	12.71%	18.22%	15.92%	13.27%	7.52%	3.86%	9.49%	8.00%	2.24%	0.59%
Debt-free Net Working Capital to Revenue	28.79%	20.54%	22.77%	24.46%	27.45%	61.98%	34.69%	34.98%	48.80%	35.44%	17.17%
Net Working Capital to Revenue	28.79%	19.33%	20.63%	24.46%	27.45%	61.98%	-8.43%	34.98%	48.80%	19.76%	17.17%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.86	$0.02	$0.55	$0.96	$1.48	$0.76	$1.79	$0.13	($0.45)	$0.27	$0.04
Adjusted Weighted Average Basic Shares Outstanding	35.86M	36.16M	37.48M	39.24M	41.46M	42.58M	43.48M	44.40M	45.21M	46.05M	45.97M
Adjusted Diluted Earnings per Share	$0.84	$0.02	$0.53	$0.93	$1.43	$0.74	$1.62	$0.12	($0.45)	$0.27	$0.04
Adjusted Weighted Average Diluted Shares Outstanding	36.72M	36.86M	38.71M	40.56M	42.94M	43.74M	47.94M	45.89M	45.21M	46.26M	46.36M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	35.83M	36.95M	38.78M	40.80M	42.47M	43.04M	44.42M	44.99M	45.92M	46.76M	45.44M
Normalized Net Operating Profit after Tax (NOPAT)	30	16	7.80	31	65	25	63	-1.63	-24	0.24	3.61
Normalized NOPAT Margin	6.20%	2.31%	1.09%	3.95%	7.25%	2.79%	5.53%	-0.13%	-2.13%	0.02%	0.30%
Pre Tax Income Margin	9.54%	1.86%	0.63%	4.52%	8.24%	3.29%	5.83%	-0.19%	-1.75%	2.30%	0.96%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	162.62%	0.00%	0.00%	0.00%	0.00%	164.74%	0.00%	924.40%	0.00%	0.00%	3,781.68%

This table displays calculated financial ratios and metrics derived from Omnicell's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	45,435,918.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	45,435,918.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0.25
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-14.19%	-13.04%	-15.30%	-7.42%	-5.44%	18.56%	9.55%	4.98%	9.99%	2.32%	14.91%
EBITDA Growth	-25.78%	165.61%	54.79%	-14.30%	6.79%	622.06%	106.33%	2.66%	-7.01%	-50.78%	190.53%
EBIT Growth	-57.37%	47.86%	15.82%	-32.86%	57.50%	227.45%	46.55%	27.52%	-16.55%	-97.04%	277.39%
NOPAT Growth	-84.39%	39.09%	4.86%	-32.92%	74.48%	150.88%	46.82%	198.19%	-4.75%	-114.46%	239.23%
Net Income Growth	-66.90%	49.40%	-4.51%	8.23%	55.41%	210.21%	55.20%	50.98%	-36.71%	-112.79%	261.73%
EPS Growth	-67.57%	48.39%	-3.03%	0.00%	58.33%	206.25%	55.88%	50.00%	-36.84%	-114.71%	266.67%
Operating Cash Flow Growth	169.22%	-53.24%	291.17%	-19.48%	-60.09%	46.60%	-48.10%	-27.16%	24.23%	-46.10%	110.23%
Free Cash Flow Firm Growth	142.10%	155.25%	1,031.42%	40.81%	-36.26%	41.76%	-74.88%	-86.93%	-64.25%	-87.23%	39.06%
Invested Capital Growth	-8.73%	-5.54%	-8.97%	-8.63%	-5.86%	-5.87%	-2.82%	-0.89%	-1.99%	-0.98%	-2.16%
Revenue Q/Q Growth	-0.10%	-13.33%	-4.90%	12.45%	2.03%	8.66%	-12.13%	7.75%	6.91%	1.08%	-1.31%
EBITDA Q/Q Growth	-14.28%	-79.79%	-2.20%	405.71%	6.82%	36.67%	-72.05%	151.61%	-3.24%	-27.66%	64.96%
EBIT Q/Q Growth	-39.54%	-350.84%	3.70%	145.97%	41.84%	102.98%	-140.38%	209.69%	-7.18%	-92.80%	2,318.45%
NOPAT Q/Q Growth	27.50%	-685.74%	6.50%	109.61%	231.65%	70.79%	-197.74%	153.86%	5.94%	-125.92%	1,041.41%
Net Income Q/Q Growth	60.91%	-358.87%	-9.05%	123.83%	131.06%	83.57%	-144.33%	180.29%	-3.14%	-137.09%	660.61%
EPS Q/Q Growth	50.00%	-366.67%	-6.25%	123.53%	137.50%	78.95%	-144.12%	180.00%	0.00%	-141.67%	600.00%
Operating Cash Flow Q/Q Growth	-21.80%	-32.62%	30.04%	17.51%	-61.24%	147.49%	-53.97%	64.92%	-33.89%	7.38%	79.55%
Free Cash Flow Firm Q/Q Growth	54.91%	-53.67%	81.15%	8.31%	-29.87%	3.03%	-67.90%	-43.66%	91.89%	-63.21%	249.63%
Invested Capital Q/Q Growth	-1.71%	-1.44%	-3.41%	-2.36%	1.27%	-1.45%	-0.27%	-0.42%	0.14%	-0.43%	-1.46%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.18%	40.72%	37.63%	41.31%	43.29%	46.19%	41.14%	43.94%	43.30%	41.51%	45.30%
EBITDA Margin	10.71%	2.50%	2.57%	11.55%	12.09%	15.21%	4.84%	11.30%	10.23%	7.32%	12.23%
Operating Margin	1.24%	-9.03%	-8.88%	1.16%	2.32%	4.04%	-4.31%	2.79%	2.65%	0.13%	5.44%
EBIT Margin	2.47%	-7.15%	-7.24%	2.96%	4.12%	7.69%	-3.53%	3.60%	3.12%	0.22%	5.46%
Profit (Net Income) Margin	1.86%	-5.55%	-6.37%	1.35%	3.06%	5.16%	-2.60%	1.94%	1.76%	-0.65%	3.67%
Tax Burden Percent	75.22%	77.63%	87.91%	45.57%	74.22%	67.13%	73.69%	53.95%	56.29%	-289.84%	67.19%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	24.78%	0.00%	0.00%	54.43%	25.78%	32.87%	0.00%	46.05%	43.71%	389.84%	32.81%
Return on Invested Capital (ROIC)	0.81%	-5.46%	-5.24%	0.45%	1.44%	2.41%	-2.79%	1.43%	1.44%	-0.38%	3.74%
ROIC Less NNEP Spread (ROIC-NNEP)	2.12%	-4.28%	-5.51%	2.93%	7.53%	22.95%	14.96%	-4.45%	-12.98%	2.49%	3.68%
Return on Net Nonoperating Assets (RNNOA)	0.38%	-0.62%	-0.67%	0.23%	0.38%	0.69%	0.08%	0.08%	0.06%	-0.06%	-0.17%
Return on Equity (ROE)	1.19%	-6.08%	-5.91%	0.68%	1.83%	3.10%	-2.71%	1.51%	1.50%	-0.43%	3.56%
Cash Return on Invested Capital (CROIC)	6.59%	3.86%	7.58%	6.92%	4.09%	6.06%	3.40%	1.71%	2.83%	1.07%	3.71%
Operating Return on Assets (OROA)	1.33%	-3.70%	-3.52%	1.43%	1.94%	3.93%	-1.81%	1.86%	1.73%	0.13%	3.22%
Return on Assets (ROA)	1.00%	-2.87%	-3.10%	0.65%	1.44%	2.64%	-1.33%	1.01%	0.97%	-0.37%	2.16%
Return on Common Equity (ROCE)	1.19%	-6.08%	-5.91%	0.68%	1.83%	3.10%	-2.71%	1.51%	1.50%	-0.43%	3.56%
Return on Equity Simple (ROE_SIMPLE)	-2.90%	0.00%	-1.77%	-1.73%	-1.44%	0.00%	1.69%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	2.79	-16	-15	1.47	4.87	8.32	-8.13	4.38	4.64	-1.20	11
NOPAT Margin	0.93%	-6.32%	-6.21%	0.53%	1.73%	2.71%	-3.02%	1.51%	1.49%	-0.38%	3.65%
Net Nonoperating Expense Percent (NNEP)	-1.31%	-1.17%	0.27%	-2.48%	-6.09%	-20.55%	-17.75%	5.88%	14.42%	-2.87%	0.06%
Return On Investment Capital (ROIC_SIMPLE)	-	-0.93%	-0.87%	-	-	0.53%	-0.51%	0.27%	0.33%	-0.09%	0.79%
Cost of Revenue to Revenue	55.82%	59.28%	62.37%	58.69%	56.71%	53.81%	58.86%	56.06%	56.70%	58.49%	54.70%
SG&A Expenses to Revenue	34.81%	39.39%	37.54%	32.52%	33.46%	33.67%	37.84%	33.72%	32.91%	34.19%	32.91%
R&D to Revenue	8.13%	10.36%	8.96%	7.62%	7.51%	8.49%	7.61%	7.42%	7.73%	7.18%	6.94%
Operating Expenses to Revenue	42.94%	49.75%	46.50%	40.15%	40.97%	42.16%	45.45%	41.15%	40.65%	41.37%	39.86%
Earnings before Interest and Taxes (EBIT)	7.38	-19	-18	8.20	12	24	-9.53	10	9.70	0.70	17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	32	6.47	6.32	32	34	47	13	33	32	23	38
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.71	1.44	1.13	1.03	1.63	1.66	1.30	1.09	1.15	1.65	1.21
Price to Tangible Book Value (P/TBV)	8.69	7.07	5.41	4.64	6.68	6.44	4.83	3.96	4.50	6.28	4.29
Price to Revenue (P/Rev)	1.72	1.49	1.22	1.15	1.88	1.85	1.44	1.20	1.19	1.72	1.24
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	164.55	77.17	59.65	70.22	990.70	74.23
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.61%	1.30%	1.68%	1.42%	0.10%	1.35%
Enterprise Value to Invested Capital (EV/IC)	1.65	1.40	1.12	1.03	1.63	1.67	1.31	1.09	1.15	1.67	1.22
Enterprise Value to Revenue (EV/Rev)	1.82	1.58	1.27	1.16	1.89	1.83	1.40	1.15	1.18	1.69	1.18
Enterprise Value to EBITDA (EV/EBITDA)	33.98	22.70	17.06	16.39	25.43	17.07	12.63	10.42	11.15	19.92	11.52
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	79.46	46.89	36.51	40.49	176.95	38.28
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	12,324.22	240.66	133.68	138.92	2,143.41	79.41
Enterprise Value to Operating Cash Flow (EV/OCF)	9.60	10.01	6.41	6.16	11.82	10.83	9.71	8.93	9.04	15.74	9.27
Enterprise Value to Free Cash Flow (EV/FCFF)	23.87	35.34	14.12	14.26	38.60	26.77	38.07	63.74	40.14	155.61	32.53
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.48	0.48	0.48	0.47	0.46	0.27	0.27	0.27	0.14	0.14	0.13
Long-Term Debt to Equity	0.48	0.48	0.48	0.47	0.00	0.13	0.13	0.13	0.14	0.14	0.13
Financial Leverage	0.18	0.15	0.12	0.08	0.05	0.03	0.01	-0.02	0.00	-0.02	-0.05
Leverage Ratio	1.89	1.91	1.95	1.90	1.87	1.79	1.81	1.80	1.73	1.65	1.65
Compound Leverage Factor	1.89	1.91	1.95	1.90	1.87	1.79	1.81	1.80	1.73	1.65	1.65
Debt to Total Capital	32.39%	32.39%	32.43%	32.20%	31.72%	21.51%	21.35%	21.29%	12.05%	11.98%	11.79%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	31.72%	11.01%	10.92%	10.89%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	32.39%	32.39%	32.43%	32.20%	0.00%	10.50%	10.43%	10.40%	12.05%	11.98%	11.79%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	67.61%	67.61%	67.57%	67.80%	68.28%	78.49%	78.65%	78.71%	87.95%	88.02%	88.21%
Debt to EBITDA	8.95	7.13	6.95	7.44	7.25	2.86	2.71	2.70	1.35	1.67	1.34
Net Debt to EBITDA	1.92	1.27	0.71	0.19	0.02	-0.24	-0.36	-0.45	-0.10	-0.29	-0.57
Long-Term Debt to EBITDA	8.95	7.13	6.95	7.44	0.00	1.40	1.32	1.32	1.35	1.67	1.34
Debt to NOPAT	-16.30	-23.34	-24.14	-21.32	-23.07	2,064.93	51.68	34.61	16.77	179.26	9.23
Net Debt to NOPAT	-3.50	-4.17	-2.46	-0.54	-0.06	-172.60	-6.90	-5.79	-1.28	-30.94	-3.92
Long-Term Debt to NOPAT	-16.30	-23.34	-24.14	-21.32	0.00	1,008.44	25.25	16.91	16.77	179.26	9.23
Altman Z-Score	2.26	2.01	1.71	1.70	1.85	2.35	1.98	1.88	2.18	2.64	2.28
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.47	2.52	2.38	2.45	1.05	1.37	1.38	1.42	1.44	1.43	1.50
Quick Ratio	1.95	1.96	1.83	1.96	0.86	1.05	1.05	1.06	0.93	0.87	1.01
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	128	59	108	116	82	84	27	15	29	11	38
Operating Cash Flow to CapEx	536.18%	423.53%	557.70%	614.60%	256.59%	619.73%	232.04%	362.91%	289.83%	393.75%	438.28%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.54	0.52	0.49	0.48	0.47	0.51	0.51	0.52	0.55	0.58	0.59
Accounts Receivable Turnover	3.78	4.16	3.86	4.20	4.06	4.38	4.54	4.85	4.73	5.01	4.89
Inventory Turnover	5.11	5.05	5.22	5.68	5.96	6.45	6.64	6.50	6.55	7.19	7.27
Fixed Asset Turnover	12.15	11.33	10.63	10.09	9.74	10.05	10.10	10.00	10.18	10.18	10.33
Accounts Payable Turnover	10.90	12.00	11.98	13.12	12.88	13.25	13.41	11.54	12.02	14.23	12.40
Days Sales Outstanding (DSO)	96.44	87.74	94.44	86.99	89.92	83.42	80.36	75.22	77.09	72.90	74.69
Days Inventory Outstanding (DIO)	71.41	72.31	69.95	64.22	61.22	56.57	54.94	56.16	55.75	50.77	50.19
Days Payable Outstanding (DPO)	33.49	30.43	30.47	27.81	28.33	27.55	27.22	31.64	30.37	25.65	29.43
Cash Conversion Cycle (CCC)	134.36	129.62	133.92	123.40	122.81	112.44	108.08	99.73	102.47	98.02	95.45
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,309	1,291	1,247	1,217	1,233	1,215	1,212	1,206	1,208	1,203	1,185
Invested Capital Turnover	0.86	0.86	0.84	0.85	0.84	0.89	0.92	0.95	0.97	0.98	1.02
Increase / (Decrease) in Invested Capital	-125	-76	-123	-115	-77	-76	-35	-11	-25	-12	-26
Enterprise Value (EV)	2,158	1,813	1,400	1,258	2,007	2,034	1,589	1,320	1,386	2,004	1,445
Market Capitalization	2,036	1,711	1,342	1,243	2,005	2,062	1,635	1,377	1,399	2,033	1,517
Book Value per Share	$26.26	$26.15	$25.89	$26.19	$26.77	$26.84	$26.88	$26.98	$26.58	$27.45	$27.66
Tangible Book Value per Share	$5.18	$5.32	$5.40	$5.84	$6.53	$6.92	$7.24	$7.42	$6.77	$7.21	$7.79
Total Capital	1,756	1,759	1,759	1,774	1,803	1,584	1,598	1,605	1,388	1,399	1,425
Total Debt	569	570	570	571	572	341	341	342	167	168	168
Total Long-Term Debt	569	570	570	571	0.00	166	167	167	167	168	168
Net Debt	122	102	58	14	1.37	-28	-46	-57	-13	-29	-71
Capital Expenditures (CapEx)	11	9.07	8.96	9.55	8.87	9.09	11	12	9.75	7.71	12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	98	92	61	32	51	25	20	26	23	6.94	0.03
Debt-free Net Working Capital (DFNWC)	544	560	574	589	622	394	407	425	203	203	239
Net Working Capital (NWC)	544	560	574	589	50	220	232	250	203	203	239
Net Nonoperating Expense (NNE)	-2.76	-1.98	0.38	-2.27	-3.76	-7.52	-1.11	-1.26	-0.82	0.82	-0.03
Net Nonoperating Obligations (NNO)	122	102	58	14	1.37	-28	-46	-57	-13	-29	-71
Total Depreciation and Amortization (D&A)	25	25	24	24	23	23	23	22	22	22	21
Debt-free, Cash-free Net Working Capital to Revenue	8.23%	8.00%	5.55%	2.94%	4.80%	2.24%	1.75%	2.28%	1.95%	0.59%	0.00%
Debt-free Net Working Capital to Revenue	45.90%	48.80%	52.02%	54.47%	58.42%	35.44%	35.81%	36.99%	17.24%	17.17%	19.53%
Net Working Capital to Revenue	45.90%	48.80%	52.02%	54.47%	4.67%	19.76%	20.44%	21.78%	17.24%	17.17%	19.53%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.12	($0.32)	($0.34)	$0.08	$0.19	$0.34	($0.15)	$0.12	$0.12	($0.05)	$0.25
Adjusted Weighted Average Basic Shares Outstanding	45.33M	45.21M	45.73M	45.95M	46.15M	46.05M	46.60M	46.79M	45.54M	45.97M	45.32M
Adjusted Diluted Earnings per Share	$0.12	($0.32)	($0.34)	$0.08	$0.19	$0.34	($0.15)	$0.12	$0.12	($0.05)	$0.25
Adjusted Weighted Average Diluted Shares Outstanding	45.60M	45.21M	45.73M	46.04M	46.43M	46.26M	46.60M	46.99M	45.90M	46.36M	45.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	45.47M	45.92M	45.92M	45.99M	46.32M	46.76M	46.84M	45.93M	44.88M	45.44M	45.48M
Normalized Net Operating Profit after Tax (NOPAT)	2.79	-16	-15	2.26	4.87	8.32	-8.13	4.38	4.64	0.29	11
Normalized NOPAT Margin	0.93%	-6.32%	-6.21%	0.82%	1.73%	2.71%	-3.02%	1.51%	1.49%	0.09%	3.65%
Pre Tax Income Margin	2.47%	-7.15%	-7.24%	2.96%	4.12%	7.69%	-3.53%	3.60%	3.12%	0.22%	5.46%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	67.79%	389.56%	3,781.68%	0.00%

Financials Breakdown Chart

Key Financial Trends

Below are the key takeaways from Omnicell (OMCL) across the last four years, based on the quarterly income statements, balance sheets, and cash flow statements provided (2022–2025). The focus is on trends that may impact retail investors’ view of the stock’s trajectory, profitability, and liquidity.

Revenue resilience in late 2025: Q4 2025 operating revenue was $313.98M, up from $306.88M in Q4 2024 (+2.3%), marking a return to growth after some volatility in prior years.
Operating income turns positive in the latest quarter: Q4 2025 reported operating income of about $0.42M, a positive reading after years of negative operating income in several prior quarters.
Earnings per share improve meaningfully: Basic and diluted EPS for Q4 2025 come in at -$0.05, an improvement from -$0.65 in Q4 2024, indicating narrowing losses on a per-share basis.
Cash flow from continuing operations remains positive: Q4 2025 net cash from continuing operating activities was $30.35M, indicating ongoing cash generation to support operations.
Solid quarterly cash improvement versus prior year quarter: Net change in cash and equivalents for Q4 2025 was +$25.58M, reversing a sizable cash outflow in Q4 2024 and signaling improved near-term liquidity.
Balance sheet asset mix reflects acquisitions: Goodwill around $737.9M and intangible assets near $172–194M across periods indicate ongoing acquisition activity and asset-light positioning shifts; this is a neutral factor for near-term cash flow but could affect future amortization and impairment risk.
No short-term debt reported in the latest quarter: Short-Term Debt is $0.0, suggesting manageable near-term liquidity needs at the end of Q4 2025; this is a neutral signal for liquidity readiness.
Gross margin compression persists: Gross margin declined to approximately 41.4% in Q4 2025 from about 46.2% in Q4 2024, indicating margin pressure that could impact sustained profitability if selling prices or costs don’t improve.
Rising leverage: Long-term debt increased to roughly $167.3M by 2025, up from negligible levels in earlier periods, signaling higher financial leverage that could weigh on risk if cash flows don’t strengthen.
Net loss remains, though narrower: Net income attributable to common shareholders remained negative in Q4 2025 (-$2.03M), even as losses narrowed versus prior-year quarters; the company has yet to deliver a positive annual bottom line in the latest year.

05/12/26 09:59 AM ETAI Generated. May Contain Errors.

Omnicell Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Omnicell's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Omnicell's net income appears to be on a downward trend, with a most recent value of $2.05 million in 2025, falling from $30.76 million in 2015. The previous period was $12.53 million in 2024. Check out Omnicell's forecast to explore projected trends and price targets.

Omnicell's total operating income in 2025 was $5.16 million, based on the following breakdown:

Total Gross Profit: $503.44 million
Total Operating Expenses: $498.28 million

Over the last 10 years, Omnicell's total revenue changed from $484.56 million in 2015 to $1.18 billion in 2025, a change of 144.5%.

Omnicell's total liabilities were at $742.91 million at the end of 2025, a 15.4% decrease from 2024, and a 321.2% increase since 2015.

In the past 10 years, Omnicell's cash and equivalents has ranged from $32.42 million in 2017 to $485.93 million in 2020, and is currently $196.52 million as of their latest financial filing in 2025.

Over the last 10 years, Omnicell's book value per share changed from 11.36 in 2015 to 27.45 in 2025, a change of 141.7%.

Related Companies

Financial statements for NASDAQ:OMCL last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Omnicell (OMCL) Financials

Financials Breakdown Chart

Key Financial Trends

Omnicell Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Omnicell (OMCL) Financials

Annual Income Statements for Omnicell

Quarterly Income Statements for Omnicell

Annual Cash Flow Statements for Omnicell

Quarterly Cash Flow Statements for Omnicell

Annual Balance Sheets for Omnicell

Quarterly Balance Sheets for Omnicell

Annual Metrics And Ratios for Omnicell

Quarterly Metrics And Ratios for Omnicell

Financials Breakdown Chart

Key Financial Trends

Omnicell Financials - Frequently Asked Questions

When does Omnicell's financial year end?

How has Omnicell's net income changed over the last 10 years?

What is Omnicell's operating income?

How has Omnicell's revenue changed over the last 10 years?

How much debt does Omnicell have?

How much cash does Omnicell have?

How has Omnicell's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools